Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,000
Closed -$1.53M 234
2023
Q2
$1.53M Buy
+14,000
New +$1.49M 0.01% 229
2022
Q2
Sell
-61,100
Closed -$7.23M 527
2022
Q1
$7.23M Buy
+61,100
New +$7.57M 0.03% 184
2021
Q2
Sell
-29,600
Closed -$3.55M 824
2021
Q1
$3.55M Buy
29,600
+12,300
+71% +$1.46M 0.02% 353
2020
Q4
$1.89M Buy
17,300
+7,300
+73% +$793K 0.01% 433
2020
Q3
$1.09M Buy
+10,000
New +$1.01M 0.01% 430
2019
Q4
Sell
-96,500
Closed -$8.07M 656
2019
Q3
$8.07M Buy
96,500
+87,800
+1,009% +$7.46M 0.1% 152
2019
Q2
$732K Sell
8,700
-49,400
-85% -$3.89M 0.01% 460
2019
Q1
$4.64M Buy
+58,100
New +$4.32M 0.05% 340

Other funds holding ABT

HBK Investments's ABT Position: Q2 2022 in Review

HBK Investments sold out of Abbott (ABT) in Q2 2022, closing a stake of 6,600 shares — an estimated $781K sold.

HBK Investments first reported a position in ABT in Q2 2013 and held it in 10 quarters. The position peaked at $8.88M in Q4 2020. 2,696 funds tracked by Wall St. Rank hold ABT as of Q2 2022.

  • HBK Investments reported no remaining Abbott position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 6,600 Abbott shares in Q2 2022, an estimated $781K.
  • HBK Investments first reported a position in Abbott in Q2 2013 and held it in 10 quarters.
  • HBK Investments's Abbott position peaked at $8.88M in Q4 2020.
  • 2,696 funds tracked by Wall St. Rank held Abbott as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.